Theravance Biopharma (0TB) Revenue

0 Followers

Theravance Biopharma Revenue

Theravance Biopharma had a revenue of 20.73M in the quarter ending Jun 30, 2026, with 17.13%. This bring the company's revenue in the last twelve months to 104.31M, Increased -4.98%. In the fiscal year ending Dec 31, 2025, Theravance Biopharma had annual revenue of 107.46M with 66.92% growth.

Revenue (ttm)

104.31M

Revenue Growth

26.64%

P/S Ratio

7.17

Revenue/Employee

€1,194,044

Employees

Market Cap

€770.07M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	107.46M	43.08M	+66.92%
Dec 31, 2024	64.38M	6.96M	+12.12%
Dec 31, 2023	57.42M	6.08M	+11.84%
Dec 31, 2022	51.35M	-3.96M	-7.17%
Dec 31, 2021	55.31M	-16.55M	-23.03%
Dec 31, 2020	71.86M	-1.56M	-2.12%
Dec 31, 2019	73.41M	13.04M	+21.61%
Dec 31, 2018	60.37M	44.98M	+292.37%
Dec 31, 2017	15.39M	―	―